[HTML][HTML] Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft
E Loggi, F Bihl, JV Chisholm III, M Biselli… - Journal of …, 2009 - Elsevier
BACKGROUND/AIMS: Orthotopic liver transplantation (OLT) is an important therapeutic
option for HBV-related end-stage-liver disease, yet it is often hampered by a scarcity of
organ availability. One option to increase organ availability is the use of virologically
compromised organs from HBV-infected donors. Transplantation of anti-HBcore positive
grafts has been associated with a low risk of HBV recurrence if adequately treated with
nucleoside analogs, irrespective of concomitant HBV-specific immunoglobulin therapy …
option for HBV-related end-stage-liver disease, yet it is often hampered by a scarcity of
organ availability. One option to increase organ availability is the use of virologically
compromised organs from HBV-infected donors. Transplantation of anti-HBcore positive
grafts has been associated with a low risk of HBV recurrence if adequately treated with
nucleoside analogs, irrespective of concomitant HBV-specific immunoglobulin therapy …